Lumos enhanced imaging receives FDA clearance

The FDA has recently given EndoChoice clearance for its Lumos imaging software system, which can improve detection and provide clearer images to physicians.

Lumos contains two different settings for giving physicians better images for detection of abnormal tissues. The first setting is capable of enhancing images of tissues that have been selected, the second setting gives further insight into the inspection of the tissues. A study was conducted to show the just how well Lumos worked and results showed enhanced images of lesions with pit patterns, leading to a quicker detection of the tissue abnormalities.

"Other image processing technologies alter the image, which can be distracting. With Lumos, only anatomy that has certain textures, vascularity or abnormal anatomy is enhanced, allowing me to keep my focus on potentially diseased tissue" said Peter Siersema, MD PhD, Professor of Endoscopic Gastrointestinal Oncology at Radboud University Medical Center, Nijmegen, The Netherlands.